Suppr超能文献

胰高血糖素通过降低该酶的琥珀酰化程度在体内激活线粒体3-羟基-3-甲基戊二酰辅酶A合酶。

Glucagon activates mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase in vivo by decreasing the extent of succinylation of the enzyme.

作者信息

Quant P A, Tubbs P K, Brand M D

机构信息

Department of Biochemistry, University of Cambridge, England.

出版信息

Eur J Biochem. 1990 Jan 12;187(1):169-74. doi: 10.1111/j.1432-1033.1990.tb15291.x.

Abstract
  1. 3-Hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase (EC 4.1.3.5) in extracts of rat liver mitochondria can be inactivated by succinyl-CoA and activated by incubation in a medium designed to cause desuccinylation ('desuccinylation medium'). 2. The enzyme is less active in extracts of whole liver from control rats than from rats treated with glucagon or mannoheptulose. Incubation in desuccinylation medium raises the activity in extracts from control rats to the same value as treated rats, suggesting that the extent of succinylation in vivo is greater in controls than in hormone-treated animals. 3. This result is also obtained in liver homogenates and in isolated mitochondria. 4. Increasing the succinyl-CoA content of mitochondria to the same high level lowers the enzyme activity to the same value in mitochondria isolated from control or treated rats. In each case subsequent incubation of the lysates in desuccinylation medium raises the enzyme activity by the same extent. 5. Measurement of the incorporation of radiolabel from 2-oxo[5-14C]glutarate into protein is consistent with the proposal that all these changes in activity in isolated mitochondria may be explained by changes in the extent of succinylation of the enzyme. 6. From these data and our earlier work we conclude that, in vivo, mitochondrial HMG-CoA synthase in fed rats is normally substantially succinylated (about 40%) and inactivated, and that glucagon increases the activity of HMG-CoA synthase by lowering the concentration of succinyl-CoA and thus decreasing the extent of succinylation of the enzyme (to less than 10%). This may be an important control mechanism in ketogenesis.
摘要
  1. 大鼠肝脏线粒体提取物中的3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)合酶(EC 4.1.3.5)可被琥珀酰辅酶A灭活,并在旨在导致去琥珀酰化的培养基(“去琥珀酰化培养基”)中孵育而被激活。2. 对照大鼠全肝提取物中的该酶活性低于用胰高血糖素或甘露庚酮糖处理的大鼠。在去琥珀酰化培养基中孵育可使对照大鼠提取物中的活性升高至与处理大鼠相同的值,这表明对照动物体内的琥珀酰化程度高于激素处理的动物。3. 在肝脏匀浆和分离的线粒体中也得到了这一结果。4. 将线粒体的琥珀酰辅酶A含量增加到相同的高水平,会使从对照或处理大鼠分离的线粒体中的酶活性降低到相同的值。在每种情况下,随后将裂解物在去琥珀酰化培养基中孵育,酶活性会升高相同的程度。5. 对从2-氧代[5-¹⁴C]戊二酸掺入蛋白质中的放射性标记的测量结果与以下提议一致,即分离的线粒体中所有这些活性变化都可以通过酶的琥珀酰化程度变化来解释。6. 根据这些数据和我们早期的工作,我们得出结论,在体内,喂食大鼠的线粒体HMG-CoA合酶通常大量被琥珀酰化(约40%)并失活,而胰高血糖素通过降低琥珀酰辅酶A的浓度从而降低酶的琥珀酰化程度(至小于10%)来增加HMG-CoA合酶的活性。这可能是生酮作用中的一种重要控制机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验